60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
60 Degrees Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$8.89M. For fiscal 2025 it was -$6.99M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.99M | – |
| FY2024 | Dec 31, 2024 | -$5.75M | – |
| FY2023 | Dec 31, 2023 | -$4.60M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.23M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.69M | – |
| Q4 FY2023 | Dec 31, 2023 | -$119.47K | – |